This Project Grant award of $727,972.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is funding a study to understand racial/ethnic disparities in clinician concordance with hypertension treatment guidelines and blood pressure control. The primary objectives are to: 1) evaluate the extent of racial disparity in hypertension treatment based on the 2017 AHA/ACC guidelines in the Southeastern U.S.; 2) investigate patient, provider, clinic, and...
This $103,948 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a study examining the association between discrimination reported during pregnancy and later cardiovascular disease (CVD) risk in mothers. The 2-year study, led by the University of Denver, will assess maternal CVD risk factors such as body mass index, blood pressure, and arterial stiffness at 3-4 years postpartum. The research also explores whether adverse...
This Project Grant award, valued at $708,794.00 and granted by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to identify optimal dietary patterns for postpartum cardiovascular disease prevention. The research will establish the role of longitudinal dietary patterns in the development of cardiovascular disease and risk factors from periconception to 10 years postpartum, and explore how social determinants of health...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $602,099 to the Icahn School of Medicine at Mount Sinai to conduct a longitudinal study on the impact of structural racism during pregnancy on future cardiopulmonary health outcomes. The study, titled "The Impact of Structural Racism During Pregnancy on Future Cardiopulmonary Health" (Gen C Mamas), will follow 440...
This Project Grant award for $2,559,308 from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA 93.837 Cardiovascular Diseases Research, supports a study titled "SHEPREG: STUDY OF HEART FUNCTION IN PRE-ECLAMPSIA DURING AND AFTER PREGNANCY". The study aims to examine the impact of severe pre-eclampsia on heart function in women from diverse racial backgrounds, evaluating heart function at delivery and 6-12 months postpartum. The project will characterize the...
This federal Project Grant award of $241,500.00 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will support research at Duke University to investigate racial/ethnic disparities in hypertensive disorders during pregnancy in the United States. The key objectives of this project are to: 1) Develop and validate a Markov state-transition model to simulate the natural history of hypertensive disorders in pregnancy...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $869,696 to Vanderbilt University Medical Center to investigate the relationship between preeclampsia during pregnancy and the development of heart failure with preserved ejection fraction (HFpEF) in women. The key objectives are to: 1) measure the relationship between post-partum subclinical left ventricular diastolic dysfunction and...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant will fund a 12-week proof-of-concept study testing a technology-delivered mindful walking intervention to reduce stress, increase physical activity, and lower blood pressure in Black women with hypertension. The project aims to address disparities in hypertension and physical activity rates among...
This federal Project Grant award, valued at $1,888,904.00 and awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to reduce the risk of chronic hypertension and improve vascular function following preeclampsia. The research focuses on the mechanisms behind the increased risk of cardiovascular disease in patients who have experienced hypertensive disorders of pregnancy,...
This $132,410 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will provide protected time for Dr. Cheryl Anderson, a mid-career clinical investigator, to recruit and mentor a diverse group of trainees in clinical cardiovascular epidemiology and health equity research. The award will support two new areas of research: 1) integrating global policy and strategy into multilevel interventions to improve...